Eileen P. Connolly
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Robert J. SchneiderSilvia C. FormentiSteve BraunsteinJeffrey M. FriedmanElla IoffeDavid P. HorowitzByoung C. MoonRichard Ha
- Topics
- Breast Cancer Treatment Studies (23 papers)Breast Lesions and Carcinomas (12 papers)Glioma Diagnosis and Treatment (10 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Biological Chemistry
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Eileen P. Connolly
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 364
- Cancer Research 354
- Oncology 298
- Pulmonary and Respiratory Medicine 182
- Radiology, Nuclear Medicine and Imaging 180
Countries citing papers authored by Eileen P. Connolly
This map shows the geographic impact of Eileen P. Connolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen P. Connolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen P. Connolly more than expected).
Fields of papers citing papers by Eileen P. Connolly
This network shows the impact of papers produced by Eileen P. Connolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen P. Connolly. The network helps show where Eileen P. Connolly may publish in the future.
Co-authorship network of co-authors of Eileen P. Connolly
This figure shows the co-authorship network connecting the top 25 collaborators of Eileen P. Connolly. A scholar is included among the top collaborators of Eileen P. Connolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen P. Connolly. Eileen P. Connolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 20 | |
| 6 | 15 | |
| 7 | 26 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 21 | |
| 12 | 4 | |
| 13 | 26 | |
| 14 | 3 | |
| 15 | 16 | |
| 16 | 16 | |
| 17 | Overexpression of a critical target of rapamycin, translation regulatory protein 4E-BP1, is largely restricted to locally advanced breast and prostate cancers and is lost with tumor invasiveness | 1 |
| 18 | 10 | |
| 19 | 55 | |
| 20 | MIX DESIGNS AND AIR QUALITY EMISSIONS TESTS OF CRUMB RUBBER MODIFIED ASPHALT CONCRETE | 5 |
About Eileen P. Connolly
Eileen P. Connolly is a scholar working on Cancer Research, Genetics and Oncology, having authored 68 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (12 papers) and Glioma Diagnosis and Treatment (10 papers). The work is most often cited by research in Cancer Research (354 citations), Endocrine and Autonomic Systems (126 citations) and Oncology (298 citations). Eileen P. Connolly has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert J. Schneider, Silvia C. Formenti, Steve Braunstein, Jeffrey M. Friedman, Ella Ioffe, David P. Horowitz, Byoung C. Moon, Richard Ha, Israel Deutsch and Kevin Kalinsky. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.